[ad_1] Partnership to combine GeNeuro’s expertise in HERVs with Verily’s Immune Profiler and Workbench platforms to investigate biomarkers related to HERV-W GENEVA, Switzerland–(BUSINESS WIRE)– GeNeuro (Euronext Paris: CH0308403085 – GNRO),…